
This will allow Cipla to expand access to the drugs in the country with the second-highest number of diabetic people in the world. India has more than 70 million adults with diabetes.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3l6uYHx
via
IFTTT
0 comments:
Post a Comment